SCHEMBL9845182

SCHEMBL9845182

CNc1cc(C2CCCc3cncn32)ccc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 15/20 0.54
CYP11B2 P19099 6/20 0.48
CYP11B1 P15538 3/20 0.48
KCNH2 Q12809 1/20 0.48
MAPT P10636 2/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866168 0.94 CYP19A1 (0.46) CYP19A1CYP11B2CYP11B1KCNH2MAPT
SCHEMBL9845187 0.86 CYP19A1 (0.60) CYP19A1CYP11B2CYP11B1KCNH2
Nitric Acid SCHEMBL9845190 0.83 CYP19A1 (0.57) CYP19A1CYP11B2CYP11B1KCNH2
Nitric Acid SCHEMBL9845192 0.83 CYP19A1 (0.57) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL7771677 0.82 MAPT (0.46) CYP19A1CYP11B2CYP11B1KCNH2MAPT
Nitric Acid SCHEMBL9845216 0.79 CYP19A1 (0.57) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL13529265 0.79 CYP19A1 (0.60) CYP19A1CYP11B2CYP11B1KCNH2
Nitric Acid SCHEMBL9845218 0.79 CYP19A1 (0.57) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL7772876 0.77 CYP19A1 (0.49) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL7773112 0.74 CYP11B2 (0.49) CYP19A1CYP11B2CYP11B1KCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5066656-A Aromatase inhibitor, prevention of biosynthesis of estrogens, treatment of estrogen dependent disorders JANSSEN PHARMACEUTICA N.V. (BE) 1991-11-19 US disclosed
EP-0426225-A2 (6,7-dihydro-5H-pyrrolo[1,2-c]-imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1991-05-08 EP disclosed